Skip to content
Clinical Trials for Alzheimer's Disease

District of Columbia

Alzheimer's disease clinical trials in District of Columbia

5 Alzheimer's disease studies are recruiting participants at sites in 1 city across District of Columbia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every District of Columbia city with a recruiting study

Washington D.C. (5).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in District of Columbia

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Washington D.C.
    Registry record
    NCT06976216 · updated
  2. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Recruiting in
    Washington D.C.
    Registry record
    NCT06808984 · updated
  3. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    Washington D.C.
    Registry record
    NCT06563895 · updated
  4. Late Onset Alzheimer's Disease

    • Observational
    • Ages 55 and older
    • All sexes
    Sponsor
    Columbia University
    Recruiting in
    Washington D.C.
    Registry record
    NCT05010603 · updated
  5. DC Longitudinal Study on Aging and Specimen Bank

    • Observational
    • Ages 45 and older
    • All sexes
    Sponsor
    Georgetown University
    Recruiting in
    Washington D.C.
    Registry record
    NCT03702907 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in District of Columbia on ClinicalTrials.gov.

Ask about studies in District of Columbia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call